BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35583829)

  • 1. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.
    Tober R; Schnetzke U; Fleischmann M; Yomade O; Schrenk K; Hammersen J; Glaser A; Thiede C; Hochhaus A; Scholl S
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1569-1583. PubMed ID: 35583829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of antifungal prophylaxis in patients diagnosed with acute leukemias undergoing induction chemotherapy: a systematic review and meta-analysis.
    Soldi LR; Coelho YNB; Paranhos LR; Silva MJB
    Clin Exp Med; 2023 Nov; 23(7):3231-3249. PubMed ID: 37058186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia.
    Tu S; Zhang K; Wang N; Chu J; Yang L; Xie Z
    Sci Rep; 2023 Nov; 13(1):18789. PubMed ID: 37914820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial.
    Saber-Moghaddam N; Nodeh MM; Ghavami V; Rahimi H; Azimi SA; Seddigh-Shamsi M; Kamandi M; Allahyari A; Shariatmaghani SS; Elyasi S; Arasteh O
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4355-4364. PubMed ID: 38095652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.
    Cernan M; Szotkowski T; Hubacek J; Kolar M; Faber E; Indrak K; Papajik T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):236-245. PubMed ID: 35258041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of prophylactic anidulafungin during remission induction of acute myeloid leukemia - A propensity-score matching analysis.
    Silva WFD; Mendes FR; Melo RDCB; Velloso EDRP; Rocha V; Rego EM
    J Mycol Med; 2023 Nov; 33(4):101434. PubMed ID: 37683564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents.
    Scamuffa MC; Latagliata R; Carmosino I; Di Veroli A; Scalzulli E; Trapè G; Ciotti G; De Angelis G; Tartaglia G; Tarnani M; Breccia M; Girmenia C
    Leuk Lymphoma; 2023; 64(11):1840-1846. PubMed ID: 37554018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
    Galloway-Peña JR; Shi Y; Peterson CB; Sahasrabhojane P; Gopalakrishnan V; Brumlow CE; Daver NG; Alfayez M; Boddu PC; Khan MAW; Wargo JA; Do KA; Jenq RR; Kontoyiannis DP; Shelburne SA
    Clin Infect Dis; 2020 Jun; 71(1):63-71. PubMed ID: 31436833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature review.
    Barańska M; Kroll-Balcerzak R; Gil L; Rupa-Matysek J; Komarnicki M
    Cent Eur J Immunol; 2017; 42(1):111-115. PubMed ID: 28680340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) study.
    Baucher L; Lemiale V; Joseph A; Wallet F; Pineton de Chambrun M; Ferré A; Lombardi R; Platon L; Contejean A; Fuseau C; Calvet L; Pène F; Kouatchet A; Mokart D; Azoulay E; Lafarge A
    Ann Intensive Care; 2023 Dec; 13(1):123. PubMed ID: 38055081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia.
    Cornely OA; Ostermann H; Koehler P; Teschner D; Limburg E; Kramer WG; Barbat SH; Tawadrous M; Hodges MR
    J Antimicrob Chemother; 2023 Nov; 78(11):2645-2652. PubMed ID: 37681450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormographiella aspergillata pulmonary infections: Detection and identification of the fungus using pan-fungal PCR assays and DNA sequencing.
    Nevez G; Guillerm G; Talarmin JP; Quinio D; Iriart X; Lissillour PL; Rezig S; Fangous MS; Ranty M; Bodenes L; Aubron C; Couturier MA; Le Gal S
    J Mycol Med; 2024 Mar; 34(1):101463. PubMed ID: 38342037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.
    Klepin HD; Geiger AM; Tooze JA; Kritchevsky SB; Williamson JD; Pardee TS; Ellis LR; Powell BL
    Blood; 2013 May; 121(21):4287-94. PubMed ID: 23550038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.
    Tramsen L; Salzmann-Manrique E; Bochennek K; Klingebiel T; Reinhardt D; Creutzig U; Sung L; Lehrnbecher T
    J Clin Oncol; 2016 Aug; 34(23):2776-83. PubMed ID: 27269945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of patients with acute myeloid leukemia admitted to intensive care unit with acute respiratory failure: a post-hoc analysis of a prospective multicenter study.
    Secreto C; Chean D; van de Louw A; Kouatchet A; Bauer P; Cerrano M; Lengliné E; Saillard C; Chow-Chine L; Perner A; Pickkers P; Soares M; Rello J; Pène F; Lemiale V; Darmon M; Fodil S; Martin-Loeches I; Mehta S; Schellongowski P; Azoulay E; Mokart D
    Ann Intensive Care; 2023 Sep; 13(1):79. PubMed ID: 37658994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations.
    Vaughn JE; Buckley SA; Walter RB
    Leuk Res; 2016 Jun; 45():53-8. PubMed ID: 27101148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole and levofloxacin prophylaxis are ineffective strategies for preventing infections in acute myeloid leukemia patients undergoing chemotherapy.
    Soldi LR; Silva MJB
    Cancer Epidemiol; 2024 May; 91():102593. PubMed ID: 38815484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older Patients With Acute Myeloid Leukemia: Treatment Challenges and Future Directions.
    Finn L; Dalovisio A; Foran J
    Ochsner J; 2017; 17(4):398-404. PubMed ID: 29230125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal infections in pediatric patients with central nervous system tumors: novel insights for prophylactic treatments?
    Dassi N; Cappellano AM; da Silva AMPS; da Silva NS; Carlesse FAMC
    Front Oncol; 2023; 13():1248082. PubMed ID: 37965468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection-related mortality and infection control practices in childhood acute myeloid leukemia in a limited resource setting: Experience with the Indonesian national protocol.
    Supriyadi E; Purwanto I; Widiastuti Z; Armytasari I; Sandi S; Ardianto B; Kaspers GJL
    Belitung Nurs J; 2024; 10(2):185-191. PubMed ID: 38690309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.